Table of Contents

Articles

• You have access

  Characterization of the Selectivity and Mechanism of Human Cytochrome P450 Inhibition by the Human Immunodeficiency Virus-Protease Inhibitor Nelfinavir Mesylate

  James H. Lillibridge, Bai Hong Liang, Bradley M. Kerr, Stephanie Webber, Barry Quart, Bhasker V. Shetty and Caroline A. Lee

  Drug Metabolism and Disposition July 1998, 26 (7) 609-616;
• You have access

  Minimal Interaction Between Fluoxetine and Multiple-Dose Zolpidem in Healthy Women

  Stéphane Allard, Stephen Sainati, Barbara Roth-Schechter and John MacIntyre

  Drug Metabolism and Disposition July 1998, 26 (7) 617-622;
• You have access

  Reversible Fatty Acid Conjugation of Budesonide

  A. Miller-Larsson, H. Mattsson, E. Hjertberg, M. Dahlbäck, A. Tunek and R. Brattsand

  Drug Metabolism and Disposition July 1998, 26 (7) 623-630;
• You have access

  Metabolism of Delavirdine, a Human Immunodeficiency Virus Type-1 Reverse Transcriptase Inhibitor, by Microsomal Cytochrome P450 in Humans, Rats, and Other Species: Probable Involvement of CYP2D6 and CYP3A

  Richard L. Voorman, Stephen M. Maio, Michael J. Hauer, Philip E. Sanders, N. Ann Payne and Mark J. Ackland

  Drug Metabolism and Disposition July 1998, 26 (7) 631-639;
• You have access

  Biotransformation of Cerivastatin in Mice, Rats, and Dogsin vivo

  Michael Boberg, Rolf Angerbauer, Wolfgang K. Kanhai, Wolfgang Karl, Armin Kern, Martin Radtke and Wolfram Steinke

  Drug Metabolism and Disposition July 1998, 26 (7) 640-652;
• You have access

  Calcium Binding by Human and Rabbit Serum Paraoxonases

  Chung-Liang Kuo and Bert N. La Du

  Drug Metabolism and Disposition July 1998, 26 (7) 653-660;
• You have access

  Hepatic Disposition and Toxicity of Cationized Goat Immunoglobulin G and Fab Fragments in Isolated Perfused Rat Liver

  G. Hong, M. Bazin-Redureau, P. Gires and J. M. Scherrmann

  Drug Metabolism and Disposition July 1998, 26 (7) 661-669;
• You have access

  Pharmacokinetics of an Antisense Oligonucleotide Injected Intravitreally in Monkeys

  Janet M. Leeds, Scott P. Henry, Steve Bistner, Scott Scherrill, Kevin Williams and Arthur A. Levin

  Drug Metabolism and Disposition July 1998, 26 (7) 670-675;
• You have access

  Oxidation of a Metabolite of Indomethacin (Desmethyldeschlorobenzoylindomethacin) to Reactive Intermediates by Activated Neutrophils, Hypochlorous Acid, and the Myeloperoxidase System

  C. Ju and J. P. Uetrecht

  Drug Metabolism and Disposition July 1998, 26 (7) 676-680;
• You have access

  Enantioselective, Mechanism-Based Inactivation of Guinea Pig Hepatic Cytochrome P450 byN-(α-Methylbenzyl)-1-Aminobenzotriazole

  Christopher J. Sinal, Maurice Hirst, Christopher D. Webb and John R. Bend

  Drug Metabolism and Disposition July 1998, 26 (7) 681-688;
• You have access

  Fentanyl in Hair

  Peter R. Stout, David J. Claffey and James A. Ruth

  Drug Metabolism and Disposition July 1998, 26 (7) 689-700;
• You have access

  (R)-(+)-Menthofuran Is a Potent, Mechanism-Based Inactivator of Human Liver Cytochrome P450 2A6

  Siamak C. Khojasteh-Bakht, Luke L. Koenigs, Raimund M. Peter, William F. Trager and Sidney D. Nelson

  Drug Metabolism and Disposition July 1998, 26 (7) 701-704;
• You have access

  Biotransformation of Nitroso Aromatic Compounds and 2-Oxo Acids to N-Hydroxy-N-arylacylamides by Thiamine-Dependent Enzymes in Rat Liver

  Tadao Yoshioka and Takayoshi Uematsu

  Drug Metabolism and Disposition July 1998, 26 (7) 705-710;